Filter
684
Text search:
drug
formulations
Featured
Recommendations
85
New Publications
211
Language
Document type
No document type
407
Guidelines
131
Studies & Reports
82
Manuals
31
Training Material
11
Strategic & Response Plan
8
Fact sheets
8
Situation Updates
2
Resource Platforms
2
App
1
Infographics
1
Countries / Regions
India
51
Kenya
27
Global
18
Ethiopia
15
South Africa
15
Malawi
15
Western and Central Europe
13
Tanzania
11
Nepal
10
Bangladesh
10
Sierra Leone
9
Africa
9
Nigeria
8
Uganda
8
Zimbabwe
8
Liberia
7
Ghana
7
Philippines
7
Zambia
7
Rwanda
7
Myanmar / Burma
7
Latin America and the Carribbean
7
Namibia
6
South–East Asia Region
6
Eastern Europe
6
Cameroon
4
Cambodia
4
Eswatini/ Swaziland
4
Senegal
3
Haiti
3
Syria
3
Benin
3
Botswana
3
Burkina Faso
2
Indonesia
2
East and Southern Africa
2
Middle East and North Africa
2
Russia
2
Congo, Democratic Republic of
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Niger
1
Pakistan
1
South Sudan
1
Afghanistan
1
Thailand
1
Malaysia
1
Mozambique
1
Argentina
1
Peru
1
Brazil
1
Ukraine
1
Colombia
1
Bolivia
1
Madagascar
1
Lesotho
1
Sri Lanka
1
Chile
1
Yemen
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Paraguay
1
Bhutan
1
Venezuela
1
Congo-Brazzaville
1
Tajikistan
1
Australia
1
Georgia
1
North America
1
France
1
Authors & Publishers
Publication Years
Category
Countries
252
Clinical Guidelines
130
Public Health
35
Women & Child Health
33
Key Resources
15
Pharmacy & Technologies
15
Capacity Building
10
Toolboxes
HIV
100
TB
89
Pharmacy
63
AMR
40
Mental Health
32
COVID-19
16
NTDs
16
NCDs
15
Rapid Response
10
Ebola
8
Caregiver
8
Refugee
5
Planetary Health
5
Disability
4
Conflict
4
Cholera
3
Polio
2
Specific Hazards
2
Global Health Education
2
Health Financing Toolbox
2
Zika
1
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Accessed: 08.10.2019
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB,
...
Technical information note. Ensuring an uninterrupted supply of quality-assured, affordable anti-TB
drugs and diagnostics to the world
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
Policy brief. July 2020
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone refere
...
4th edition. This is fourth edition of Treatment of tuberculosis: guidelines, adhering fully to the new WHO process for evidence-based guidelines. Several important recommendations are being promoted in this new edition
Guidelines for treatment of drug-susceptible tuberculosis and patient care
2017 update
WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support
recommended
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis,
...